TMED

T. Rowe Price Health Care ETF

HealthcareNASDAQ-GMT. Rowe Price ETF
$35.65
$-0.23 (-0.63%)
Delayed ≥20 min · Sep 4, 2026

Key Statistics

Net Assets (AUM)
$31.56M
Expense Ratio
See prospectus
Previous Close
$35.87
Day Range
- – -
52-Week Range
$25.37 – $36.72
Volume
3.35K
Avg Vol (50D)
-
Beta
0.46

Historical Performance

1M
+3.07%
3M
+13.34%
6M
+21.41%
YTD
+19.93%
1Y
+40.48%
3Y
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

ELI LILLY & CO 14.48%
UNITEDHEALTH GROUP INC 6.54%
THERMO FISHER SCIENTIFIC INC 4.59%
GILEAD SCIENCES INC 4.14%
ABBOTT LABORATORIES 3.91%
DANAHER CORP 2.73%
MEDTRONIC PLC 2.24%
ALNYLAM PHARMACEUTICALS INC 2.06%
STRYKER CORP 2.00%
DYNE THERAPEUTICS INC 1.88%
WATERS CORP 1.75%
BECTON DICKINSON AND CO 1.71%
AGILENT TECHNOLOGIES INC 1.69%
ELANCO ANIMAL HEALTH INC 1.59%
HUMANA INC 1.57%
CYTOKINETICS INC 1.54%
WEST PHARMACEUTICAL SERVICES 1.48%
BOSTON SCIENTIFIC CORP 1.47%
ASCENDIS PHARMA A/S - ADR 1.39%
BIOGEN INC 1.26%
VAXCYTE INC 1.19%
IMMUNOME INC 1.15%
METTLER-TOLEDO INTERNATIONAL 1.11%
CENCORA INC 1.06%
APELLIS PHARMACEUTICALS INC 1.02%

Top 25 holdings as of Mar 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About TMED

The fund normally invests at least 80% of its net assets (plusany borrowings for investment purposes) in the securities of health care companies. The fund defines health care companies as companiesengaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciencestools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities.The fund references the MSCI GICS (Global Industry Classification Standard) Health Care sector to identify such companies. Anyderivatives that provide exposure to the investment focus suggested by the fund’s name, or to one or more market risk factorsassociated with the investment focus suggested by the fund’s name, are counted (as applicable) toward compliance with thefund’s 80% investment policy. As a fundamental policy, the fund will concentrate (invest morethan 25% of its net assets) in health care companies. The majority of the fund will be invested in equity securities,such as common stocks. While most assets are typically invested in U.S. common stocks, the fund may invest in foreign stocks inkeeping with its objective. The fund uses fundamental, bottom-up analysis and may investin companies of any market capitalization. The adviser may use both growth and value approaches in selecting investments for thefund. The fund is nondiversified, which means it may invest a greaterpercentage of its assets in a particular issuer than is permissible for a diversified fund. 

TMED News

  • No recent news found for TMED.

Data for TMED is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.